We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
28 Nov 2020 - 30 Nov 2020
Virtual Venue

Pre-Operative MRI Effective in Women with Dense Breasts

By HospiMedica International staff writers
Posted on 11 Nov 2020
Print article
Image: Pre-operative MRI detects more occult tumor sites in women with dense breasts imaged DBT (Photo courtesy of iStock)
Image: Pre-operative MRI detects more occult tumor sites in women with dense breasts imaged DBT (Photo courtesy of iStock)
Pre-operative MRI can catch more breast cancer lesions in women with dense breasts who receive an initial diagnosis via digital breast tomosynthesis (DBT), according to a new study.

Researchers at the University of Pennsylvania (Penn; Philadelphia, USA) conducted a retrospective study of 388 preoperative MRI exams for newly detected breast cancer identified either by digital mammography (DM) or DBT, in order to assess the role of MRI in assessment of tumor extent. MRI detection of occult disease was stratified by modality, breast density, and background parenchymal enhancement. A true-positive finding was defined as malignancy in the ipsilateral-breast at least two cm away from the index-lesion, or in the contralateral breast.

The results revealed 50 additional malignancies (12.9%), 37 of them ipsilateral and 13 contralateral. But while in DM there was no significant difference in the rate of MRI additional cancer detection in dense breasts, in those who underwent DBT, significantly more additional sites of malignancy were detected. In addition, in both DM and DBT cohorts, higher background parenchymal enhancement was associated with higher false-positive rates, but no significant difference was found in true-positive exams. The study was published on October 13, 2020, in Clinical Imaging.

“We found a trend of increasing detection by MRI of additional sites of malignancies in patients with dense breasts compared to those with non-dense breasts, irrespective of initial imaging modality,” said senior author Elizabeth McDonald, MD, PhD. “These findings suggest that in women imaged with DBT, MRI may have less value for determining extent of disease than in women with non-dense breasts. Women with dense breasts appear to benefit more from pre-operative MRI than non-dense women.”

Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.

Related Links:
University of Pennsylvania


Print article
M.I ONE Co., Ltd
Gentherm

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.